X. Ye

发表

Developing adenoviral-mediated in vivo gene therapy for ornithine transcarbamylase deficiency

M. Yudkoff, J. Wilson, S. Raper, 1998, Journal of Inherited Metabolic Disease.

Liver bypass significantly increases the transduction efficiency of recombinant adenoviral vectors in the lung, intestine, and kidney.

P. Ray, M. Jerebtsova, X. Ye, 2000, Human gene therapy.

Prospects for prenatal gene therapy in disorders causing mental retardation.

M. Mitchell, X. Ye, K. Newman, 2001, Mental retardation and developmental disabilities research reviews.

Adenovirus-Mediated in Vivo Gene Transfer Rapidly Protects Ornithine Transcarbamylase-Deficient Mice from an Ammonium Challenge

M. Robinson, M. Batshaw, J. M. Wilson, 1997, Pediatric Research.

Evaluating the potential of germ line transmission after intravenous administration of recombinant adenovirus in the C3H mouse.

J. Wilson, G. Gao, S. Raper, 1998, Human gene therapy.

Selective gene transfer into the liver of non-human primates with E1-deleted, E2A-defective, or E1-E4 deleted recombinant adenoviruses.

E. Furth, J. Wilson, G. Gao, 1998, Human gene therapy.

Humoral Immune Response to Recombinant Adenovirus and Adeno-Associated Virus after In Utero Administration of Viral Vectors in Mice

M. Batshaw, M. Jerebtsova, X. Ye, 2002, Pediatric Research.

Correction of argininosuccinate synthetase (AS) deficiency in a murine model of citrullinemia with recombinant adenovirus carrying human AS cDNA

M. Jerebtsova, X. Ye, M. Batshaw, 2000, Gene Therapy.

In vivo measurement of ureagenesis with stable isotopes

M. Yudkoff, J. Wilson, M. Batshaw, 1998, Journal of Inherited Metabolic Disease.

Prospects for gene therapy in ornithine carbamoyltransferase deficiency and other urea cycle disorders

M. Robinson, M. Batshaw, J. M. Wilson, 1995 .

Prolonged Metabolic Correction in Adult Ornithine Transcarbamylase-deficient Mice with Adenoviral Vectors (*)

E. Furth, M. Robinson, M. Batshaw, 1996, The Journal of Biological Chemistry.

A simple technique to establish a long-term adenovirus mediated gene transfer to the heart of newborn mice.

P. Ray, M. Jerebtsova, X. Ye, 2009, Cardiovascular & hematological disorders drug targets.

Adenovirus-mediated gene transfer to glomerular cells in newborn mice

P. Ray, M. Jerebtsova, X. Ye, 2005, Pediatric Nephrology.

Long-term regulated expression of growth hormone in mice after intramuscular gene transfer.

V. Rivera, J. Wilson, M. Gilman, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver.

J. Wilson, J. Engelhardt, B. Doranz, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer.

V. Rivera, P. Zoltick, J. Wilson, 1999, Science.

Transient depletion of CD4 lymphocyte improves efficacy of repeated administration of recombinant adenovirus in the ornithine transcarbamylase deficient sparse fur mouse

J. Wilson, M. Robinson, X Ye, 2000, Gene Therapy.

Adenovirus-mediated gene transfer to renal glomeruli in rodents.

Zhuangwu Li, P. Ray, M. Jerebtsova, 2002, Kidney international.

Efficient gene transfer to rat renal glomeruli with recombinant adenoviral vectors.

Zhuangwu Li, P. Ray, X. Liu, 2001, Human gene therapy.

Differences in the human and mouse amino-terminal leader peptides of ornithine transcarbamylase affect mitochondrial import and efficacy of adenoviral vectors.

J. Wilson, K. Zimmer, M. Robinson, 2001, Human gene therapy.

Long-term gene transfer to mouse fetuses with recombinant adenovirus and adeno-associated virus (AAV) vectors

M. Mitchell, M. Jerebtsova, X. Ye, 2000, Gene Therapy.

Pharmacologically regulated gene expression in the retina following transduction with viral vectors

J. Bennett, J. Wilson, G. Gao, 2001, Gene Therapy.

Efficient Mitochondrial Import of Newly Synthesized Ornithine Transcarbamylase (OTC) and Correction of Secondary Metabolic Alterations in spfash Mice following Gene Therapy of OTC Deficiency

E. Kominami, K. Zimmer, M. Mori, 1999, Molecular medicine.

Timely immunization subverts the development of peripheral nonresponsiveness and suppresses tumor development in simian virus 40 tumor antigen-transgenic mice.

B. Knowles, J. Mccarrick, X. Ye, 1994, Proceedings of the National Academy of Sciences of the United States of America.